trending Market Intelligence /marketintelligence/en/news-insights/trending/oIprNGwJy6VGkxY9cE82WA2 content esgSubNav
In This List

Impax Laboratories CEO resigns, interim appointed

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Impax Laboratories CEO resigns, interim appointed

G. Frederick Wilkinson is stepping down as Impax Laboratories Inc.'s president and CEO, to be replaced by J. Kevin Buchi on an interim basis.

Wilkinson was also a director of the company.